What is the price target for MELE stock?
20 analysts have analysed MELE.BR and the average price target is 64.3 EUR. This implies a price increase of 26.45% is expected in the next year compared to the current price of 50.85.
EBR:MELE • BE0165385973
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MELEXIS NV (MELE.BR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-07 | Jefferies | Upgrade | Hold -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 964.298M 15.32% | 932.808M -3.27% | 839.617M -9.99% | 872.55M 3.92% | 949.4M 8.81% | 1.028B 8.28% | 1.149B 11.77% | 1.189B 3.48% | 1.244B 4.63% | 1.388B 11.58% | 1.506B 8.50% | |
| EBITDA YoY % growth | 313.755M 13.30% | 274.498M -12.51% | 187.302M -31.77% | 207.48M 10.77% | 246.3M 18.71% | 282.43M 14.67% | 351.38M 24.41% | 329.99M -6.09% | 285.76M -13.40% | 444.07M 55.40% | 520.13M 17.13% | |
| EBIT YoY % growth | 268.586M 15.90% | 226.757M -15.57% | 133.963M -40.92% | 157.33M 17.44% | 193.86M 23.22% | 225.52M 16.33% | 272.21M 20.70% | 276.76M 1.67% | 295.24M 6.68% | 344.54M 16.70% | 373.66M 8.45% | |
| Operating Margin | 27.85% | 24.31% | 15.96% | 18.03% | 20.42% | 21.94% | 23.69% | 23.28% | 23.73% | 24.82% | 24.81% | |
| EPS YoY % growth | 5.18 6.15% | 4.23 -18.34% | 2.79 -34.04% | 3.05 9.26% | 3.84 25.89% | 4.53 18.16% | 5.83 28.67% | 5.38 -7.84% | 4.52 -15.89% | 7.51 66.14% | 8.87 18.06% |
All data in EUR
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.73 19.14% | 0.83 -11.75% | 1.02 50.10% | 1.03 83.42% | 1.01 38.95% | 1.09 31.45% | 1.24 21.22% | 1.17 13.70% |
| Revenue Q2Q % growth | 212.04M 6.96% | 222.91M 5.35% | 249.86M 16.06% | 254.79M 18.79% | 254.18M 19.87% | 264.35M 18.59% | 277.57M 11.09% | 282.84M 11.01% |
| EBITDA Q2Q % growth | 48.286M 17.04% | 53.244M -14.62% | 62.396M -20.11% | 59.527M -29.82% | 63.468M 31.44% | 67.884M 27.50% | 75.75M 21.40% | 72.344M 21.53% |
| EBIT Q2Q % growth | 35.906M 23.89% | 41.12M 15.34% | 50.648M 33.83% | 50.767M 61.25% | 51.013M 42.07% | 54.93M 33.58% | 62.15M 22.71% | 58.484M 15.20% |
All data in EUR
20 analysts have analysed MELE.BR and the average price target is 64.3 EUR. This implies a price increase of 26.45% is expected in the next year compared to the current price of 50.85.
MELEXIS NV (MELE.BR) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of MELEXIS NV (MELE.BR) is 0.73 EUR and the consensus revenue estimate is 212.04M EUR.
The number of analysts covering MELEXIS NV (MELE.BR) is 20.